Christopher Mills - 01 Jul 2023 Form 3 Insider Report for Renalytix plc (RNLXY)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
03 Jul 2023, 16:23:03 UTC
Next SEC filing
22 Nov 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Katie Kazem, Attorney-in-Fact

Key filing fact

Christopher Mills filed Form 3 for Renalytix plc (RNLXY) on 03 Jul 2023.

Key facts

  • This page summarizes Christopher Mills's Form 3 filing for Renalytix plc (RNLXY).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 03 Jul 2023, 16:23.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RNLX holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
6,458,582
Date
01 Jul 2023
Ownership
By North Atlantic Smaller Companies Investment Trust plc
Footnotes
F1, F2
RNLX holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,812,794
Date
01 Jul 2023
Ownership
By Oryx International Growth Fund Limited
Footnotes
F1, F3
RNLX holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
801,124
Date
01 Jul 2023
Ownership
By Harwood Capital LLP
Footnotes
F1, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The Ordinary Shares may be represented by American Depositary Shares, each representing two Ordinary Shares.

Footnote F2

The securities are directly held by North Atlantic Smaller Companies Investment Trust plc ("North Atlantic"). The Reporting Person is the Partner and Chief Investment Officer of Harwood Capital LLP ("Harwood"). Harwood is the Investment Manager to North Atlantic. The Reporting Person disclaims beneficial ownership of the securities held by North Atlantic except to the extent of his pecuniary interest therein.

Footnote F3

The securities are directly held by Oryx International Growth Fund Limited ("Oryx"). The Reporting Person is the Partner and Chief Investment Officer of Harwood. Harwood is the investment adviser to Oryx. The Reporting Person disclaims beneficial ownership of the securities held by Oryx except to the extent of his pecuniary interest therein.

Footnote F4

The securities are directly held by Harwood. The Reporting Person is the Partner and Chief Investment Officer of Harwood. The Reporting Person disclaims beneficial ownership of the securities held by Harwood except to the extent of his pecuniary interest therein.

SEC remarks

Exhibit List - Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .